It is hoped that the test will help detect cancer at a much earlier stage

Trial results and cost-effectiveness are too uncertain for NHS use, the Institute said

Tepotinib could be the first treatment on the market for NSCLC in adults harbouring METex14 skipping alterations

The combination is the first available to treat the underlying cause of CF in this patient group.

A GP has been struck off the UK medical register for an alleged sexual assault of which a […]

The world’s fastest whole-body PET/CT scanner is being put into service today at Bern University Hospital’s Inselspital Department […]

An exciting research project with current relevance and a wide range of possible applications is currently underway at […]

Chancellor Rishi Sunak hands out extra £3 billion to NHS and £14.6 billion in funding for R&D

Tremfya is a first-in-class treatment for the disease, shown to improve disease measures and quality of life

Delivery of vaccine doses to EU could begin by early 2021